U101 capsules to prevent recurring UTIs in women
Part of Infections, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests an oral capsule called U101 to see if it can prevent recurrent urinary tract infections (UTIs) in women who have frequent UTIs. If you've had at least 2 UTIs in the last 6 months or 3 in the last year, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 20 to 75 years old.
- You are not pregnant, nursing, or planning to become pregnant during the study.
- You've had at least 2 UTIs in the past 6 months or at least 3 in the past year, with at least one confirmed by a urine test.
- Your most recent urine culture (before starting the study) must show no infection.
- You have no signs of a current UTI (like burning or pain while peeing) on the day the study starts.
- You do not have serious liver, kidney, bleeding, or immune system problems, and you are not taking certain medications or treatments for UTIs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a simple sugar called D-mannose can help prevent repeat urinary tract infections (UTIs) in postmenopausal women. If you have had frequent UTIs, this trial will see if D-mannose is a good option to keep you infection-free.
This trial studies different ways to prevent repeated bladder (urinary tract) infections in women. It may help people who keep getting these infections by testing safer or more effective prevention strategies.
This trial tests two approaches to prevent repeat bladder infections in postmenopausal women: a daily antibiotic pill or a vaginal tablet containing healthy bacteria and estrogen. The goal is to see which method works better over 6 months.
This trial studies ASTARTE™, a probiotic, to see if it can reduce repeat urinary tract infections (UTIs). It may help people who get UTIs often by testing whether the supplement lowers how frequently they come back.
This trial tests a therapy (called GAG therapy) to prevent repeat urinary tract infections (UTIs) in adult women. It compares how similar the results are to a well-known antibiotic standard (nitrofurantoin) to see if it works reliably.
This study tests a new medicine called TUL108 in a small group of healthy people to see if it is safe and how the body handles it. You would receive either one dose or multiple doses of the medicine or a placebo, and your health will be closely monitored.
Hear when a new Recurrent Urinary Tract Infections in Women trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.